Innoviva, Inc. (INVA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Innoviva, Inc. (INVA) is up 4.9% since the beginning of the year. At $21 per share, INVA is trading 16.6% below its 52-week high of $25. Investors who bought $1,000 worth of INVA shares 5 years ago would now be looking at an investment worth $1,479.

Innoviva, Inc. (INVA) has returned 4.90% so far this year and 12.56% over the past 12 months. Over the last ten years, INVA has returned 5.03% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.

Based on dividend-adjusted daily data since Oct 5, 2004, INVA's average daily return is +0.05%, while the average monthly return is +1.07%. At this rate, an investment would double in approximately 5.4 years.

Historically, 50% of months were positive and 50% were negative. The best month was Dec 2008 with a return of +85.5%, while the worst month was Sep 2015 at -47.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, INVA closed higher 49% of trading days. The best single day was Oct 13, 2008 with a return of +23.3%, while the worst single day was Mar 4, 2008 at -24.5%.

Innoviva, Inc. has an annualized alpha of 1.80%, beta of 0.96, and R2 of 0.16 versus S&P 500 Index. Calculated based on daily prices since October 05, 2004.

• This stock participated in 129.75% of S&P 500 Index downside but only 97.76% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.16 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

INVA ranks 61 for risk / return — above 61% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.

Innoviva, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Innoviva, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Innoviva, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Innoviva, Inc. was 84.32%, occurring on Nov 21, 2008. Recovery took 1123 trading sessions.

The current Innoviva, Inc. drawdown is 34.43%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Innoviva, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Innoviva, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.